Synthesis of aminoalkyl-substituted aurone derivatives as acetylcholinesterase inhibitors. 2015

Young Hun Lee, and Min Cheol Shin, and Yong Don Yun, and Seo Young Shin, and Jong Min Kim, and Jeong Moo Seo, and Nam-Jung Kim, and Jong Hoon Ryu, and Yong Sup Lee
Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, 26 Kyungheedae-ro, Seoul 130-701, Republic of Korea; Medicinal Chemistry Laboratory, Department of Pharmacy, College of Pharmacy, Kyung Hee University, 26 Kyungheedae-ro, Seoul 130-701, Republic of Korea.

Alzheimer's disease (AD), a progressive and neurodegenerative disorder of the brain, is the most common cause of dementia among elderly people. To date, the successful therapeutic strategy to treat AD is maintaining the levels of acetylcholine by inhibiting acetylcholinesterase (AChE). In the present study, aurone derivatives were designed and synthesized as AChE inhibitors based on the lead structure of sulfuretin. Of those synthesized, compound 10d showed ca. 1700-fold and 6-fold higher AChE inhibitory activity than sulfuretin and galantamine, respectively. This compound also ameliorated scopolamine-induced memory deficit in mice when administered orally at the dose of 1 and 2mg/kg.

UI MeSH Term Description Entries
D008297 Male Males
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001572 Benzofurans Compounds that contain a BENZENE ring fused to a furan ring. Coumarones,Diphenylbenzofuran
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Young Hun Lee, and Min Cheol Shin, and Yong Don Yun, and Seo Young Shin, and Jong Min Kim, and Jeong Moo Seo, and Nam-Jung Kim, and Jong Hoon Ryu, and Yong Sup Lee
February 2014, Bioorganic & medicinal chemistry,
Young Hun Lee, and Min Cheol Shin, and Yong Don Yun, and Seo Young Shin, and Jong Min Kim, and Jeong Moo Seo, and Nam-Jung Kim, and Jong Hoon Ryu, and Yong Sup Lee
December 2018, Drug development research,
Young Hun Lee, and Min Cheol Shin, and Yong Don Yun, and Seo Young Shin, and Jong Min Kim, and Jeong Moo Seo, and Nam-Jung Kim, and Jong Hoon Ryu, and Yong Sup Lee
July 2012, Archiv der Pharmazie,
Young Hun Lee, and Min Cheol Shin, and Yong Don Yun, and Seo Young Shin, and Jong Min Kim, and Jeong Moo Seo, and Nam-Jung Kim, and Jong Hoon Ryu, and Yong Sup Lee
December 2021, Journal of enzyme inhibition and medicinal chemistry,
Young Hun Lee, and Min Cheol Shin, and Yong Don Yun, and Seo Young Shin, and Jong Min Kim, and Jeong Moo Seo, and Nam-Jung Kim, and Jong Hoon Ryu, and Yong Sup Lee
May 2019, Acta pharmaceutica Sinica. B,
Young Hun Lee, and Min Cheol Shin, and Yong Don Yun, and Seo Young Shin, and Jong Min Kim, and Jeong Moo Seo, and Nam-Jung Kim, and Jong Hoon Ryu, and Yong Sup Lee
February 2024, Bioorganic chemistry,
Young Hun Lee, and Min Cheol Shin, and Yong Don Yun, and Seo Young Shin, and Jong Min Kim, and Jeong Moo Seo, and Nam-Jung Kim, and Jong Hoon Ryu, and Yong Sup Lee
January 2005, Acta poloniae pharmaceutica,
Young Hun Lee, and Min Cheol Shin, and Yong Don Yun, and Seo Young Shin, and Jong Min Kim, and Jeong Moo Seo, and Nam-Jung Kim, and Jong Hoon Ryu, and Yong Sup Lee
July 2017, Bioorganic & medicinal chemistry,
Young Hun Lee, and Min Cheol Shin, and Yong Don Yun, and Seo Young Shin, and Jong Min Kim, and Jeong Moo Seo, and Nam-Jung Kim, and Jong Hoon Ryu, and Yong Sup Lee
January 2021, Archiv der Pharmazie,
Young Hun Lee, and Min Cheol Shin, and Yong Don Yun, and Seo Young Shin, and Jong Min Kim, and Jeong Moo Seo, and Nam-Jung Kim, and Jong Hoon Ryu, and Yong Sup Lee
January 2023, Journal of biomolecular structure & dynamics,
Copied contents to your clipboard!